Beyond Sulfation: Integrated Immunohistochemical, Genomic, and Proteomic Profiling Identifies PAPSS1 as a Potential Regulator of Breast Cancer Progression.
4 affiliations
- 1Department of Pathology, College of Medicine and Health Sciences, Arabian Gulf University, Manama 329, Bahrain.
- 2Department of Pathology, Faculty of Medicine, Assiut University, Assiut 71515, Egypt.
- 3Department of Pathology, Salmaniya Medical Complex, Manama 329, Bahrain.
- 4Department of Oncology, Salmaniya Medical Complex, Manama 329, Bahrain.
Abstract
Background: PAPSS1 (3'-Phosphoadenosine 5'-Phosphosulfate Synthase 1) plays a central role in the sulfation process that regulates estrogen activity; however, its pattern of expression and association with clinicopathological features in breast carcinoma (BC) are not fully examined. Methods: A total of 150 BC specimens with clinicopathological and 10-year follow-up data were analyzed. PAPSS1 protein expression was assessed using immunohistochemistry (IHC) and correlated with clinicopathological parameters and patient outcome. Transcriptomic and promotor methylation analyses were performed using TCGA-BRCA through UALCAN. Proteomic data was evaluated using the CPTAC dataset, and the gene interaction network was analyzed using STRING. Results: IHC demonstrated significantly higher PAPSS1 expression in invasive carcinomas compared with non-invasive carcinoma and with normal mammary acini (p < 0.0001). High expression was associated with the presence of vascular invasion (VI) (p = 0.003), LN metastasis (p = 0.008), and higher PAPSS1 expression in tumor capillaries (p < 0.001). CPTAC analyses confirmed significantly elevated PAPSS1 in tumors versus normal tissues (p < 0.0001), particularly in stage II and III tumors, triple-negative BC, and basal stromal-related molecular subtypes. The transcriptomic data showed different expression patterns according to tissue type; it is higher in GIT tumors. The opposite was found in lung and pancreatic carcinoma. In BC, transcriptional expression was not different between normal and tumors; it was lower in higher nodal stages and highest in medullary carcinoma and in TP53-mutant tumors. Conclusions: PAPSS1 is overexpressed in BC and is associated with VI, LN metastasis, and tumor progression, suggesting a potential role in BC aggressiveness. Further studies are recommended to explore its mechanistic role.
Related
- Integrated analysis of transcriptomic and proteomic profiles identifies divergent regulatory networks for intramuscular fat in Chinese versus Western Pigs
- Integrated single-cell and proteomic profiling of pancreatic neoplasia identifies tissue markers that outperform established diagnostic markers in distinguishing cancer from precursor lesions.
- Integrated transcriptomic and proteomic profiling of RXRA-overexpressing chronic myeloid leukemia cells identifies protein kinase D as a candidate target for imatinib sensitization
- Integrated transcriptomics identifies key genes and pathways driving CKD to ESRD progression: implications for diagnosis and prognosis
- Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis
BibTeX
@article{mohammed2026beyond,
title = {{Beyond Sulfation: Integrated Immunohistochemical, Genomic, and Proteomic Profiling Identifies PAPSS1 as a Potential Regulator of Breast Cancer Progression.}},
author = {Rabab Ahmed Ahmed Mohammed and Amina Ismaeel and Safa Alshaikh and Aalaa Mubarak and Sajedah Sabt and Samvel Selvam},
journal = {Cancers},
year = {2026},
month = sep,
doi = {10.3390/cancers18193143},
url = {https://europepmc.org/article/MED/42882838},
note = {CC BY},
}
RIS
TY - JOUR
TI - Beyond Sulfation: Integrated Immunohistochemical, Genomic, and Proteomic Profiling Identifies PAPSS1 as a Potential Regulator of Breast Cancer Progression.
AU - Rabab Ahmed Ahmed Mohammed
AU - Amina Ismaeel
AU - Safa Alshaikh
AU - Aalaa Mubarak
AU - Sajedah Sabt
AU - Samvel Selvam
PY - 2026
DA - 2026/09/29
JO - Cancers
DO - 10.3390/cancers18193143
UR - https://europepmc.org/article/MED/42882838
AB - Background: PAPSS1 (3'-Phosphoadenosine 5'-Phosphosulfate Synthase 1) plays a central role in the sulfation process that regulates estrogen activity; however, its pattern of expression and association with clinicopathological features in breast carcinoma (BC) are not fully examined. Methods: A total of 150 BC specimens with clinicopathological and 10-year follow-up data were analyzed. PAPSS1 protein expression was assessed using immunohistochemistry (IHC) and correlated with clinicopathological parameters and patient outcome. Transcriptomic and promotor methylation analyses were performed using TCGA-BRCA through UALCAN. Proteomic data was evaluated using the CPTAC dataset, and the gene interaction network was analyzed using STRING. Results: IHC demonstrated significantly higher PAPSS1 expression in invasive carcinomas compared with non-invasive carcinoma and with normal mammary acini (p < 0.0001). High expression was associated with the presence of vascular invasion (VI) (p = 0.003), LN metastasis (p = 0.008), and higher PAPSS1 expression in tumor capillaries (p < 0.001). CPTAC analyses confirmed significantly elevated PAPSS1 in tumors versus normal tissues (p < 0.0001), particularly in stage II and III tumors, triple-negative BC, and basal stromal-related molecular subtypes. The transcriptomic data showed different expression patterns according to tissue type; it is higher in GIT tumors. The opposite was found in lung and pancreatic carcinoma. In BC, transcriptional expression was not different between normal and tumors; it was lower in higher nodal stages and highest in medullary carcinoma and in TP53-mutant tumors. Conclusions: PAPSS1 is overexpressed in BC and is associated with VI, LN metastasis, and tumor progression, suggesting a potential role in BC aggressiveness. Further studies are recommended to explore its mechanistic role.
SN - 2072-6694
ER -